Search filters

List of works by Antonino Grassadonia

90K (Mac-2 BP) and galectins in tumor progression and metastasis

scientific article (publication date: 2004)

A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression

scientific article published on 03 July 2019

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.

scientific article published on 11 November 2016

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

scientific article published on 25 May 2017

Alectinib Induced Regression of Renal and Hepatic Cysts Caused by Crizotinib

scientific article published on 16 March 2020

An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors

scientific article published on May 2012

Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.

scientific article published on 9 October 2015

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

scientific article published on 16 January 2018

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey

scientific article

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review

scientific article

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study

scientific article published on November 2014

Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

scientific article published on 18 November 2019

Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer

scientific article

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

scientific article published on 22 February 2019

Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients

scientific article published on 02 January 2019

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

scientific article published on 21 February 2019

Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation"

scientific article published on 31 March 2020

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

scientific article published on 07 August 2019

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

scientific article published on 15 November 2019

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials

scientific article published on 12 December 2018

Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review

scientific article published on 12 May 2015

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

scientific article published on 20 April 2013

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

scientific article published on 12 October 2019

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

scientific article published on 07 January 2020

Expression of the 90K Tumor-Associated Protein in Benign and Malignant Melanocytic Lesions

scientific article published on 01 July 2002

FPSE-HPLC-DAD method for the quantification of anticancer drugs in human whole blood, plasma, and urine

scientific article published on 31 July 2018

Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial.

scientific article published on 20 April 2017

High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies

scientific article published on 01 January 2009

Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey

scientific article published on 22 October 2014

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

scientific article published on 15 January 2020

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study

scientific article published on 15 October 2019

Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody

scientific article published on 19 February 2014

Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?

scientific article published on 9 November 2015

Long-term outcome of breast cancer patients with pathologic N3a lymph node stage.

scientific article

Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer.

scientific article published on 13 February 2014

Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice

scientific article published on 10 October 2012

Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer

scientific article published on 29 August 2008

Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer: A Multicentric Retrospective Observational Study In Real-Life Setting.

scientific article published on 15 July 2017

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

scientific article published on 10 December 2018

Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study

scientific article published on 13 December 2019

Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma

scientific article published on 23 June 2020

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

scientific article published on 18 August 2019

Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer.

scientific article published in June 2007

Reply to Kadri Altundag: Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage?

scientific article published on 16 May 2017

Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells

scientific article

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies

scientific article published on 25 July 2013

The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides

scientific article published on July 2004

The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer

scientific article published on 17 December 2019

The flavonoid quercetin inhibits thyroid-restricted genes expression and thyroid function

scientific article published on 18 January 2014

Tumor-derived microvesicles: the metastasomes.

scientific article published on 21 November 2012

Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein.

scientific article published on 19 April 2007

Paulina is supported by:

About Paulina

Help